Beyond ALK and ROS1: RET, NTRK, EGFR and BRAF gene rearrangements in non-small cell lung cancer

由 Farago, Anna F., Azzoli, Christopher G.
發表在 Transl Lung Cancer Res (2017)

Current standards for clinical management of small cell lung cancer

由 Farago, Anna F., Keane, Florence K.
發表在 Transl Lung Cancer Res (2018)

Crossover distribution and high interference for both the X chromosome and an autosome during oogenesis and spermatogenesis in Caenorhabditis elegans.

由 Meneely, Philip M, Farago, Anna F, Kauffman, Tate M
出版 2002

Redefining the central serotonergic system based on genetic lineage

由 Jensen, Patricia, Farago, Anna F., Awatramani, Rajeshwar B., Scott, Michael M., Deneris, Evan S., Dymecki, Susan M.
出版 2008

ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one pr...

由 Farago, Anna F, Drapkin, Benjamin J, Lopez-Vilarino de Ramos, Jose Antonio, Galmarini, Carlos M, Núñez, Rafael, Kahatt, Carmen, Paz-Ares, Luis
發表在 Future Oncol (2019)

CTNI-04. ACTIVITY OF LAROTRECTINIB IN TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) METASTASES

由 Patel, Jyoti D, Farago, Anna F, Hong, David S, Lassen, Ulrik N, Leyvraz, Serge, Park, Keunchil, Sohal, Davendra P S, Solomon, Benjamin, Reeves, John A, Dima, Laura, Brega, Nicoletta, Drilon, Alexander
發表在 Neuro Oncol (2020)

Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer–Transformed EGFR Mutant Non–Small-Cell Lung Cancer

由 Mooradian, Meghan J., Piotrowska, Zofia, Drapkin, Benjamin J., Dias-Santagata, Dora, Marcoux, Nicolas, Arnaoutakis, Konstantinos, Nagy, Rebecca J., Lanman, Richard, Iafrate, Anthony J., Farago, Anna F., Mino-Kenudson, Mari, Hata, Aaron N., Sequist, Lecia V.
發表在 JCO Precis Oncol (2017)

Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses

由 Joshi, Nikhil S., Akama-Garren, Elliot H., Lu, Yisi, Lee, Da-Yae, Chang, Gregory P., Li, Amy, DuPage, Michel, Tammela, Tuomas, Kerper, Natanya R., Farago, Anna F., Robbins, Rebecca, Crowley, Denise M., Bronson, Roderick T., Jacks, Tyler
發表在 Immunity (2015)

Treatment with Next-Generation ALK Inhibitors Fuels Plasma ALK Mutation Diversity

由 Dagogo-Jack, Ibiayi, Rooney, Marguerite, Lin, Jessica J., Nagy, Rebecca J., Yeap, Beow Y., Hubbeling, Harper, Chin, Emily, Ackil, Jennifer, Farago, Anna F., Hata, Aaron N., Lennerz, Jochen K., Gainor, Justin F., Lanman, Richard B., Shaw, Alice T.
發表在 Clin Cancer Res (2019)

Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY...

由 Morgensztern, Daniel, Besse, Benjamin, Greillier, Laurent, Santana-Davila, Rafael, Ready, Neal, Hann, Christine L., Glisson, Bonnie S., Farago, Anna F., Dowlati, Afshin, Rudin, Charles M., Le Moulec, Sylvestre, Lally, Satwant, Yalamanchili, Sreeni, Wolf, Jürgen, Govindan, Ramaswamy, Carbone, David P.
發表在 Clin Cancer Res (2019)

Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032

由 Ready, Neal, Farago, Anna F., de Braud, Filippo, Atmaca, Akin, Hellmann, Matthew D., Schneider, Jeffrey G., Spigel, David R., Moreno, Victor, Chau, Ian, Hann, Christine L., Eder, Joseph Paul, Steele, Nicola L., Pieters, Anne, Fairchild, Justin, Antonia, Scott J.
發表在 J Thorac Oncol (2018)

The Art of Oncology: COVID‐19 Era

由 Reynolds, Kerry L., Klempner, Samuel J., Parikh, Aparna, Hochberg, Ephraim P., Michaelson, M. Dror, Mooradian, Meghan J., Lee, Richard J., Soumerai, Tara E., Hobbs, Gabriela, Piotrowska, Zofia, Sykes, David B., Farago, Anna F., Bardia, Aditya, Rosovsky, Rachel P., Ryan, David P.
發表在 Oncologist (2020)

Genetic and Clonal Dissection of Murine Small Cell Lung Carcinoma Progression by Genome Sequencing

由 McFadden, David G., Papagiannakopoulos, Thales, Taylor-Weiner, Amaro, Stewart, Chip, Carter, Scott L., Cibulskis, Kristian, Bhutkar, Arjun, McKenna, Aaron, Dooley, Alison, Vernon, Amanda, Sougnez, Carrie, Malstrom, Scott, Heimann, Megan, Park, Jennifer, Chen, Frances, Farago, Anna F., Dayton, Talya, Shefler, Erica, Gabriel, Stacey, Getz, Gad, Jacks, Tyler
出版 2014

Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer

由 Farago, Anna F., Le, Long P., Zheng, Zongli, Muzikansky, Alona, Drilon, Alexander, Patel, Manish, Bauer, Todd M., Liu, Stephen V., Ou, Sai-Hong I., Jackman, David, Costa, Daniel B., Multani, Pratik S., Li, Gary G., Hornby, Zachary, Chow-Maneval, Edna, Luo, David, Lim, Jonathan E., Iafrate, Anthony J., Shaw, Alice T.
發表在 J Thorac Oncol (2015)

Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non–Small-Cell Lung Cancer

由 Gainor, Justin F., Tseng, Diane, Yoda, Satoshi, Dagogo-Jack, Ibiayi, Friboulet, Luc, Lin, Jessica J., Hubbeling, Harper G., Dardaei, Leila, Farago, Anna F., Schultz, Katherine R., Ferris, Lorin A., Piotrowska, Zofia, Hardwick, James, Huang, Donghui, Mino-Kenudson, Mari, Iafrate, A. John, Hata, Aaron N., Yeap, Beow Y., Shaw, Alice T.
發表在 JCO Precis Oncol (2017)

Brigatinib in Patients with Alectinib-Refractory ALK-Positive Non-Small Cell Lung Cancer: A Retrospective Study

由 Lin, Jessica J., Zhu, Viola W., Schoenfeld, Adam J., Yeap, Beow Y., Saxena, Ashish, Ferris, Lorin A., Dagogo-Jack, Ibiayi, Farago, Anna F., Taber, Angela, Traynor, Anne, Menon, Smitha, Gainor, Justin F., Lennerz, Jochen K., Plodkowski, Andrew J., Digumarthy, Subba R., Ou, Sai-Hong Ignatius, Shaw, Alice T., Riely, Gregory J.
發表在 J Thorac Oncol (2018)

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion–Positive Non–Small-Cell Lung Cancer

由 Dziadziuszko, Rafal, Krebs, Matthew G., De Braud, Filippo, Siena, Salvatore, Drilon, Alexander, Doebele, Robert C., Patel, Manish R., Cho, Byoung Chul, Liu, Stephen V., Ahn, Myung-Ju, Chiu, Chao-Hua, Farago, Anna F., Lin, Chia-Chi, Karapetis, Christos S., Li, Yu-Chung, Day, Bann-mo, Chen, David, Wilson, Timothy R., Barlesi, Fabrice
發表在 J Clin Oncol (2021)

EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer (NSCLC): A Retrospective Analysis

由 Gainor, Justin F., Shaw, Alice T., Sequist, Lecia V., Fu, Xiujun, Azzoli, Christopher G., Piotrowska, Zofia, Huynh, Tiffany, Zhao, Ling, Fulton, Linnea, Schultz, Katherine R., Howe, Emily, Farago, Anna F., Sullivan, Ryan J., Stone, James R., Digumarthy, Subba, Moran, Teresa, Hata, Aaron N., Yagi, Yukako, Yeap, Beow Y., Engelman, Jeffrey A., Mino-Kenudson, Mari
發表在 Clin Cancer Res (2016)

Clinicopathologic Features of Non–Small-Cell Lung Cancer Harboring an NTRK Gene Fusion

由 Farago, Anna F., Taylor, Martin S., Doebele, Robert C., Zhu, Viola W., Kummar, Shivaani, Spira, Alexander I., Boyle, Theresa A., Haura, Eric B., Arcila, Maria E., Benayed, Ryma, Aisner, Dara L., Horick, Nora K., Lennerz, Jochen K., Le, Long P., Iafrate, A. John, Ou, Sai-Hong I., Shaw, Alice T., Mino-Kenudson, Mari, Drilon, Alexander
發表在 JCO Precis Oncol (2018)

Identification of DHODH as a therapeutic target in small cell lung cancer

由 Li, Leanne, Ng, Sheng Rong, Colón, Caterina I., Drapkin, Benjamin J., Hsu, Peggy P., Li, Zhaoqi, Nabel, Christopher S., Lewis, Caroline A., Romero, Rodrigo, Mercer, Kim L., Bhutkar, Arjun, Phat, Sarah, Myers, David T., Muzumdar, Mandar Deepak, Westcott, Peter M. K., Beytagh, Mary Clare, Farago, Anna F., Vander Heiden, Matthew G., Dyson, Nicholas J., Jacks, Tyler
發表在 Sci Transl Med (2019)